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Abstract
While antimicrobial and cytolytic peptides exert their effects on cells largely by interacting with the lipid bilayers of their
membranes, the influence of the cell membrane lipid composition on the specificity of these peptides towards a given
organism is not yet understood. The lack of experimental model systems that mimic the complexity of natural cell
membranes has hampered efforts to establish a direct correlation between the induced conformation of these peptides upon
binding to cell membranes and their biological specificities. Nevertheless, studies using model membranes reconstituted from
lipids and a few membrane-associated proteins, combined with spectroscopic techniques (i.e. circular dichroism, fluorescence
spectroscopy, Fourier transform infra red spectroscopy, etc.), have provided information on specific structure^function
relationships of peptide^membrane interactions at the molecular level. Reversed phase-high performance chromatography
(RP-HPLC) and surface plasmon resonance (SPR) are emerging techniques for the study of the dynamics of the interactions
between cytolytic and antimicrobial peptides and lipid surfaces. Thus, the immobilization of lipid moieties onto RP-HPLC
sorbent now allows the investigation of peptide conformational transition upon interaction with membrane surfaces, while
SPR allows the observation of the time course of peptide binding to membrane surfaces. Such studies have clearly
demonstrated the complexity of peptide^membrane interactions in terms of the mutual changes in peptide binding,
conformation, orientation, and lipid organization, and have, to a certain extent, allowed correlations to be drawn between
peptide conformational properties and lytic activity. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
The number of new antimicrobial peptides isolated
and characterized from various sources nowadays
exceeds 150 distinct molecules and continues to
grow [1]. While many conventional antibiotics dis-
able or kill bacteria over a period of days, antimicro-
bial peptides kill almost instantaneously, i.e. within
minutes. These antimicrobial peptides mostly a¡ect
cells by interacting with the lipid components of their
membranes. However, the molecular mechanism
underlying peptide-mediated cell lysis, i.e. whether
these peptides form pores, dissolve the membranes
like detergents, or induce membrane defects, remains
a matter of debate [2]. Furthermore, the inhibition of
DNA biosynthesis resulting in cell death has also
been proposed as a secondary mechanism of action
for a number of antimicrobial peptides [3^5].
Another unsolved question is the in£uence of the
cell membrane composition on peptide speci¢city to-
wards a given organism. Although many defense
peptides show a high speci¢city towards bacterial
membranes, antimicrobial peptides can also exhibit
toxicity, i.e. non-speci¢c membrane lysis, of mamma-
lian cells such as erythrocytes. There is also evidence
that some antimicrobial peptides have speci¢city for
particular membrane lipid components which in£u-
ence their secondary structure [6^9]. A better under-
standing of the molecular basis of the speci¢city
against di¡erent microbes would then facilitate the
design of more potent and speci¢c agents. Speci¢-
cally, the structural changes of antimicrobial and cy-
tolytic peptides upon interaction with membranes
not only is a function of membrane lipid composi-
tion, but also of temperature, pH, and ionic strength.
A consideration of the aqueous phase of all of these
elements is therefore essential to the understanding
of the mode of binding of these peptides. The main
reason for the di⁄culties in establishing a direct cor-
relation between the lipid-induced conformation of
lytic peptides upon binding to cell membranes and
their speci¢cities toward given organisms is the lack
of experimental model systems that mimic the com-
plexity of natural cell membranes. Indeed, biomem-
branes are complex, two-dimensional anisotropic sys-
tems whose functions are determined by their
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chemical composition, physical state and organiza-
tion, all of which are interdependent, and strongly
in£uence the induced conformation of peptides and
proteins upon binding. Nevertheless, a number of
spectroscopic techniques have been utilized to ad-
dress the peptide^lipid interaction issues using model
membranes reconstituted from lipids and a few mem-
brane-associated proteins. While information on spe-
ci¢c structure^function relationships of peptide^
membrane interactions have been obtained at the
molecular level, there is limited information on the
dynamic changes associated with the energetics of
such interactions. Recently, reversed phase-high per-
formance chromatography (RP-HPLC) and surface
plasmon resonance (SPR) have emerged as useful
techniques for the study of the dynamics of the in-
teractions between cytolytic peptides and lipid surfa-
ces. This review will focus on the use of three of the
existing spectroscopic techniques (i.e. circular dichro-
ism (CD), £uorescence spectroscopy, and Fourier
transform infrared resonance spectroscopy (FTIR)),
as well as on the use of RP-HPLC and SPR for the
study of peptide^lipid interactions. Another powerful
tool, multidimensional solid-state nuclear magnetic
resonance (NMR) spectroscopy, is the focus of the
review by Bechinger in this issue.
2. Lipid-induced peptide conformations
2.1. Common characteristics
The induction into a speci¢c conformation upon
interaction with a lipid surface has been established
as a requirement for lytic activity to occur [10,11].
The amphipathic properties of membranes provide a
unique environment for the binding of peptides,
which in£uences the peptide structure and resulting
biological activity. While the secondary structures of
cytolytic and antimicrobial peptides vary between
peptide classes, they have the common feature of
being cationic under physiological conditions
[12,13] and of forming amphipathic structures [14].
The amphipathic character enables membrane per-
meabilization and/or perturbation. The net positive
charge of these peptides is generally +2 or more,
which is believed to facilitate their interactions with
negatively charged membrane phospholipids. In par-
ticular, these peptides bind to the negatively charged
lipopolysaccharide molecules which comprise the
outer lea£et of the outer membrane of Gram-nega-
tive bacteria. Therefore, the outer membrane of
Gram-negative bacteria, which serves as barrier to
hydrophobic antibiotics, is relatively ine¡ective in
protecting these cells against cationic antimicrobial
peptides [15]. Similarly, the cationic character of
these peptides is likely to facilitate their interactions
with the negatively charged sialic acid molecules
which project out of the erythrocyte surface [16].
The insertion into the lipid bilayer of the erythrocyte
membrane, which is at a distance from the sugar
molecules, would then depend on the a⁄nity level
of the peptides for the sugar molecules (i.e. on their
cationic character and ability to cross the sugar bar-
rier). The D-enantiomers of a number of antimicro-
bial and cytolytic peptides were found to exhibit sim-
ilar activity to their L-counterpart [17^20]. This lack
of stereospeci¢city suggests that the peptides interact
with achiral components of the cell membrane and
that an appropriate hydrophobic environment is the
main requirement for peptide-mediated lysis and/or
cell death to occur.
2.2. K-Helical peptides
The two main conformations induced upon bind-
ing to membranes are the K-helix and L-sheet. Cyto-
lytic and antimicrobial K-helical peptides include me-
littin, magainin, alamethicin, cecropin A, as well as a
number of de novo designed antimicrobial peptides
(reviewed in [13]). These peptides exist as disordered
structures in aqueous solution and fold into an K-
helical conformation upon interaction with hydro-
phobic solvents or lipid surfaces. K-Helical peptides
are often found to be amphipathic and can either
absorb onto the membrane surface or insert into
the membrane as a cluster of helical bundles. While
the helical structure is well established by means of
CD, FTIR, and/or NMR, the orientation of these
peptides in the membrane remains controversial
and conclusions largely depend on the techniques
used [19,21,22]. As expected, the action of these pep-
tides on membranes appear from several studies to
be highly sensitive to the membrane lipid composi-
tion [23^30].
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2.3. L-Sheet peptides
In contrast to the linear K-helical peptides, L-sheet
peptides are cyclic peptides constrained either by di-
sul¢de bonds or cyclization of the backbone. They
largely exist in the L-sheet conformation in aqueous
solution that may be further stabilized upon interac-
tions with lipid surfaces. Defensins are among the
most characterized L-sheet-forming antimicrobial
peptides. Di¡erent mechanisms involving either the
perturbation of bilayers or the formation of discrete
channels have been suggested for these peptides
based on high resolution crystallography [31] and
2D-NMR studies [32]. Other L-sheet peptides are
the protegrins and tachyplesins which adopt hair-
pin-like L-sheet structures [33,34].
2.4. Other cytolytic and antimicrobial peptides
Other cytolytic and antimicrobial peptides include
short amino-isobutyric acid (Aib)-containing pep-
tides which adopt 310-helices [35], gramicidin A
which adopts a left-handed, antiparallel, double-
stranded L-helix [36^38], and cyclic peptides, such
as the lantibiotics [39], gramicidin S [40], and ternatin
[41]. In contrast to other antimicrobial peptides, pro-
line^arginine-rich peptides cannot form amphipathic
structures due to the incompatibility of high concen-
tration of proline residues in such structures and
have been proposed to adopt a polyproline helical
type-II structure [42,43]. Similarly, the tryptophan-
rich peptide indolicidin was reported to adopt a pol-
yproline type-II helix [44].
2.5. Antimicrobial versus cytolytic peptides
Despite the current level of the understanding of
the molecular basis of antimicrobial and cytolytic
peptide action, the de novo design of peptides having
high antimicrobial activity and low mammalian tox-
icity, or a narrow spectrum of activity, still represents
a major challenge. Since the sites of action toward
both bacterial and mammalian cells are the mem-
brane lipids, complete speci¢city represents a di⁄cult
task to achieve. However, the design of peptides hav-
ing structural properties which result in an optimal
therapeutic index has been the goal of a number of
studies. Interestingly, subtle changes in a peptide se-
quence may have a signi¢cant e¡ect on the peptide
antimicrobial and/or hemolytic activity. Thus, studies
using omission or substitution analogs of various K-
helical peptide sequences have shown that high am-
phipathicity [11,45^47], high hydrophobicity [28,45^
48], and/or high helicity [49,50] were favorable to-
ward hemolytic activity. On the other hand, de-
creases in hydrophobicity or amphipathicity resulted
in either increased [11,49^51] or decreased [45,52]
antimicrobial activities, depending on the peptides
studied. From these studies, it appeared that a de-
crease in antimicrobial activity occurs below a cer-
tain threshold of decreased amphipathicity. Low am-
phipathicity may result in a decreased a⁄nity
between the peptides and cell membranes. Recently,
similar studies using D-amino acid substitution ana-
logs of gramicidin S, a L-sheet cyclic peptide, have
agreed with the previous results and showed that
high amphipathicity and high hydrophobicity corre-
lated with high hemolytic activity, while decreased
amphipathicity resulted in increased antimicrobial
activity [53,54]. In addition to an amphipathicity
threshold, the latter studies indicated that a mini-
mum size of the peptide hydrophobic domain is re-
quired for antimicrobial activity to occur.
Based on the few di¡erences in the structural prop-
erties of the antimicrobial, non-hemolytic, peptide
cecropin A and the hemolytic and antimicrobial pep-
tide melittin (i.e. reversed polarity and di¡erent pep-
tide length), the Boman and Merri¢eld groups de-
signed cecropin A-melittin hybrid peptides with the
aim of improving the antimicrobial activity of cecro-
pin A without carrying over the toxic properties of
melittin, as well as with the aim of gaining a better
understanding of the key features in the speci¢city of
these peptides [55^57]. The hybrid concept was later
applied to generate cecropin A-magainin 2 hybrid
peptides [58,59]. A number of these hybrid peptides
were found to have enhanced antimicrobial activity
and a broader spectrum of action than either parent
sequences while showing low lytic e¡ect on mamma-
lian cells. These studies indicated that both the polar-
ity and £exibility of the molecule are key elements
for the speci¢city of these peptides.
A recent comparative study between the hemolytic
and antifungal activities of cationic peptides empha-
sized the e¡ect of assay parameters in the peptide
activities [60]. Typical activity determinations are
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carried out in high ionic strength bu¡er for hemolytic
activity and in low ionic strength bu¡er for antifun-
gal activity. However, signi¢cant di¡erences in activ-
ity were found when performing the two assays in
the same low ionic strength bu¡er, with non-hemo-
lytic peptides in standard conditions becoming hemo-
lytic in low ionic strength conditions. The hemolytic
activity of these peptides was also found to depend
on the freshness and antigen expression of the red
blood cells. While these studies did not compare the
peptide-induced conformations under such environ-
ments, ionic strength is expected to greatly in£uence
the conformation that peptides adopt in aqueous sol-
ution and therefore their interactions with cell mem-
branes. The use of standard protocols for the deter-
mination of peptide antimicrobial, antifungal, and
hemolytic activities and their relevance to in vivo
systems is obviously an important issue. This is
not, however, the focus of this review.
3. Tools to study lipid-induced conformation and
binding a⁄nity of peptides to lipid surfaces
As mentioned earlier, the di⁄culties in studying
the in£uence of cell membrane composition on the
lytic speci¢city of peptides arise from the lack of lipid
systems that mimic the complexity of natural cell
membranes and which are compatible with spectros-
copic measurements. Biomembranes consist mainly
of lipids, proteins, and carbohydrates held together
primarily by non-covalent interactions. While the
common structure of the lipid bilayer forms the basis
of membranes in all organisms, considerable varia-
tions in the structure and complexity of membranes
exist between eukaryotic and prokaryotic cells. Fur-
thermore, the structure and organization of the cell
envelope clearly di¡er in Gram-positive and Gram-
negative bacteria, while the phospholipid composi-
tions vary among strains and depend on the growth
conditions. Despite these major di¡erences, but also
because of the complexity of these systems, no exist-
ing technique has, to date, allowed a direct correla-
tion to be established between the membrane-speci¢c
characteristics and their in£uence on the lytic specif-
icities of peptides. Nevertheless, a great advance in
the understanding of the e¡ect that the membrane
lipid-composition and structure have on the induced
conformations and binding a⁄nities of peptides has
occurred in the last decade. This is mainly due to the
development of novel techniques or novel applica-
tions of existing techniques as described below. The
use of pure synthetic lipids also provides great ad-
vantages in understanding the in£uence on peptide
conformational behavior of the chemical structure,
polymorphic behavior, and dynamic properties of
the lipid membrane, as well as the in£uence of envi-
ronmental factors, such as temperature, pH, ionic
strength, hydration level, and organic co-solvent.
3.1. Circular dichroism spectroscopy
Several approaches are used in CD spectroscopy
to simulate the e¡ect of membranes on peptide con-
formations. Organic co-solvents and detergents be-
low their critical micellar concentration (cmc) have
been and still are often used to mimic the hydropho-
bic core of the membrane, whereas micelles and lipid
vesicles are applied as model membranes. Methanol,
ethanol, acetonitrile, 1,1,1,3,3,3-hexa£uoroisopropa-
nol and tri£uoroethanol (TFE) are the most fre-
quently used membrane-mimetic organic co-solvents
to determine the induced conformations relevant to
peptide antimicrobial activity [61,62]. While these
solvents are known to stabilize the secondary struc-
ture for which the sequence has propensity (i.e. K-
helix or L-sheet), the induced conformation in the
presence of these co-solvents does not necessarily re-
£ect the peptide conformation induced upon interact-
ing with lipid surfaces. For example, while the CD
and FTIR spectra of peptides corresponding to the
interaction site with lipids of the hemagglutinin of
in£uenza virus clearly indicate the induction into a
L-sheet structure in the presence of egg-phosphatidyl-
choline, the peptides fold into an K-helical conforma-
tion in 50% TFE [63]. The secondary structure of
magainin, an antimicrobial peptide from the skin of
the South African frog Xenopus laevis [64], was also
found to be di¡erent in TFE^water mixtures than in
lipidic milieu [26,65,66]. Another example is the sig-
ni¢cantly di¡erent conformations reported for melit-
tin, the main component of bee venom [67], when
bound to membranes and in the presence of deter-
gent micelles or TFE [68].
Monomeric sodium dodecyl sulfate (SDS) repre-
sents another model for lipid-like environments.
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SDS is a surfactant that can provide a hydrophobic
environment for polypeptides [61]. At low concentra-
tions (2^4 mM, i.e. below the cmc), SDS is in a
monomeric state and has been described as a mimetic
of the interior of proteins. SDS induces a L-sheet
conformation in short peptide sequences by provid-
ing a hydrophobic template that promotes the stabi-
lization of the peptide conformation through hydro-
phobic interactions between a monomeric peptide
strand and a monomeric SDS strand [69]. Thus, pep-
tides found to adopt an K-helical conformation in
TFE were induced into a distinct L-sheet structure
in the presence of low concentration of SDS [61].
At high concentrations (greater than 4 mM, i.e.
above the cmc), SDS forms micelles that are used
as mimetics of negatively charged bilayers and that
provide an anisotropic environment similar to lipid
vesicles. Micellar SDS has been reported to be a
stabilizer of K-helical conformations [61,69^71]. An
example of such variations in induced conformations
in the presence of di¡erent SDS concentrations is
shown in Fig. 1 [72]. Thus, a clear L-sheet conforma-
tion was observed in 2 mM SDS (87% L-sheet), while
the peptide showed an K-helical conformation in
both micellar SDS (80% K-helix) and lysophospha-
tidylcholine/lysophosphatidylglycerol (lpc/lpg) mi-
celles (68% K-helix). At this point, it should be noted
that lipids exhibit a di¡erent packing geometry in
micelles, than in vesicles which is expected to a¡ect
their interaction with peptides. Nevertheless, aqueous
micelles are still among the most commonly used
lipid systems. They are generated from surfactant
or lysolipid molecules [73] and have the advantage
of yielding optically transparent supramolecular lipid
aggregates, which are required for CD spectroscopy.
Liposomes or vesicles represent a more complex
model system for mimicking biological membranes
[73] and are generally classi¢ed into four groups ac-
cording to the number of lamellar and size distribu-
tion: small unilamellar vesicles (SUVs diameter 25^
50 nm), large unilamellar vesicles (LUVs diameter
around 100 nm), multilamellar vesicles (diameter
100^800 nm), and giant unilamellar vesicles (diame-
ter s 1 Wm) [74]. In a manner similar to micelles,
SUVs yield optically clear solutions and exhibit
strains in lipid packing owing to the high membrane
curvature of these small particles. This can consider-
ably a¡ect the ability of amphipathic peptides to
bind and, in particular, to insert into the hydropho-
bic core of such bilayers. To avoid such issues and to
more closely relate to natural cell membranes, LUVs
consisting of one or two lipid components are more
commonly used. Speci¢cally, comparative studies are
commonly carried out using negatively charged lipids
Table 1
Main phospholipid components of illustrative organisms
Zwitterionic Negatively charged
PE PC SM PS PG DPG lpg
E. coli IM 82 6 12
S. aureus 57 5 38
C. albicans 70 4 15 11
C. neoformans 29 51 16 4
Erythrocyte outer membrane lea£et 50 50
Fig. 1. Conformation of Ac-KYA13K-NH2 in (999) 5 mM
MOPS, pH 7.0, (9 9 9) 2 mM SDS, (- - -) 10 mM SDS, and
(9 - 9) lpc/lpg micelles [72].
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and zwitterionic lipids [2]. As illustrated in Table 1,
general information on peptide^cell-type interaction
preferences can be derived from such studies. Thus,
the main lipid components of the erythrocyte plasma
membrane are zwitterionic lipids, while Gram-posi-
tive and Gram-negative bacterial plasma membranes
as well as fungi are characterized by a comparably
large amount of negatively charged lipid [75^77]. The
in£uence of the lipid composition on peptide induced
helicity is illustrated in Fig. 2 using model peptides
and liposomes composed of the di¡erent lipid ratios
shown in Table 1.
A lipid discrimination by antimicrobial peptides
was also demonstrated for peptidyl-glycine-leucine-
carboxyamide (PGLa) [29]. This cationic, 21-amino
acid residue peptide isolated from the skin of the
South African clawed frog X. laevis [78], is practi-
cally devoid of secondary structure in aqueous envi-
ronments. Partial L-structure and a minor amount of
K-helix were detected at high peptide concentration,
suggesting the formation of aggregates which would
result in increased intermolecular hydrogen bonding
between the peptide molecules. Partial L-structure
was also observed at high temperatures for PGLa
[29] and magainin 2 [79]. PGLa did not change its
rather structureless conformation in the presence of
model membranes composed of phosphatidylcholine
(PC) and sphingomyelin (SM) [29] or of PC and
cholesterol [80], which are the predominant compo-
nents of the outer lea£et of most mammalian cell
membranes, such as the erythrocyte membranes (Ta-
ble 1). These observations indicate that PGLa does
not interact with these lipids, which correlates with
the lack of hemolytic activity of this peptide. How-
ever, PGLa exhibits a conformational change from
an unordered structure in solution to a predomi-
nantly K-helical structure (around 60%) in the pres-
ence of negatively charged liposomes composed of
phosphatidylglycerol (PG) and phosphatidylethanol-
amine (PE), lipids mimicking bacterial plasma mem-
branes (Table 1). This occurs independently of the
phase state of the lipids [29]. Magainin has a similar
behavior, although it does not exhibit sequence ho-
mology to PGLa. Thus, magainin was also found to
be unordered in aqueous solution and to adopt an K-
helix in the presence of liposomes composed of neg-
atively charged phospholipids [25,81,82].
Cecropin A, isolated from the immune hemolymph
of the moth Hyalophora cecropia [83], is composed of
two helices connected by a hinge region formed by
Gly-Pro [84], while the mammalian cecropin P1
forms a continuous K-helix [85]. From CD measure-
ments and sequence comparisons, it was suggested
that cecropin B shares the helix-hinge-helix motif of
cecropin A [86]. All of these peptides have in com-
mon an amphipathic N-terminal region with a strong
cationic face and a large hydrophobic C-terminal
region. To gain information on the role of these re-
gions with respect to membrane lysis, Wang et al.
designed two cecropin analogs, the ¢rst one having
two amphipathic helices, termed cecropin B1, and
the second one having two hydrophobic helices,
termed cecropin B3 [87]. The interaction of these
peptides with liposomes composed of varying ratios
of phosphatidic acid (PA) and PC were studied by
CD spectroscopy. Cecropin B, B1 and B3 had no
secondary structure in aqueous solution, but adopted
an K-helical structure upon interacting with lipo-
somes and SDS micelles. The extent of K-helix
formed depended on the amount of negatively
charged lipids and was most pronounced for the hy-
drophobic cecropin analog. Furthermore, binding
Fig. 2. CD spectra of YKLLKLLLPKLKGLLIKL-NH2 in
(999) Staphylococcus aureus mimetic liposomes (PG/DPG/lpg
(57/5/38)), (9 9 9) Cryptococcus neoformans mimetic liposomes
(PE/PC/PS/DPG (59/51/16/4)), (- - -) Candida albicans mimetic
liposomes (PE/PC/SM/PS (70/4/15/11)), and (9 - 9) erythrocyte
mimetic liposomes (PC/SM/cholesterol (37/37/26)). The activities
of this peptide against the respective organisms are MIC = 22,
11, and 83 Wg/ml, and HD50 = 149 Wg/ml.
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and leakage experiments revealed very similar behav-
ior for cecropin B and B1. While the binding of both
peptides increased with increasing amounts of nega-
tively charged lipids, as shown by surface plasmon
resonance, the e⁄ciency of liposome disruption de-
creased. On the other hand, binding of cecropin B3
was negligible, although cecropin B3 was more e⁄-
cient in disrupting liposomes containing a large frac-
tion of PA. Only one rate constant for each peptide
was found by stopped-£ow CD measurements, which
depended on the charge of the peptide, being fastest
for cecropin B1 (net charge 11+) and slowest for
cecropin B3 (net charge 3+), mainly re£ecting the
stronger binding to negatively charged liposomes.
This study also demonstrated that the helical struc-
ture formed early in the interaction of all of these
peptides and was maintained throughout the whole
binding process. In contrast, stopped-£ow £uores-
cence data revealed a two-step process for cecropin
B and B1 and a one-step process for cecropin B3,
which may re£ect di¡erent mechanisms of action. It
was suggested that the more cationic peptides form
pores, while the hydrophobic analog perturbs the
bilayer structure through accumulation of the hydro-
phobic peptide in PC domains [87], as had been pro-
posed earlier for cecropin P1 [88].
Covalent binding of lipids to quartz surfaces rep-
resents another route to study peptide^lipid interac-
tion by CD spectroscopy. Such an approach was ¢rst
presented with the coating of quartz plates with oc-
tadecyl groups [89,90]. To mimic an aqueous^lipid
interface, the CD spectra were recorded while the
plates were submerged in aqueous bu¡er. Using
model leucine/lysine-containing amphipathic pep-
tides, these studies clearly demonstrated the induc-
tion of K-helical or L-sheet conformations upon
binding to the C18-coated plates, with K-helical pep-
tides having higher a⁄nity for the lipid surface. The
lower binding a⁄nity observed for L-sheet peptides
may be explained by the occurrence of an equi-
librium between a multimeric self-aggregated peptide
complex and a peptide^C18-surface complex, both
being stabilized through hydrophobic interactions.
In a manner similar to the monomeric SDS hydro-
carbon chain, the C18-coated plates can then be en-
visioned as a hydrophobic template mimicking a hy-
drophobic strand necessary for monomeric L-sheet
induction. Similar induced conformations were re-
cently presented for the NC1 domain of chicken col-
lagen upon interacting with CD quartz plates that
were coated with C4, C8, and C18 groups [91].
Although this method does not allow a precise quan-
titation of the extent of the induced conformation, it
remains a powerful technique for the evaluation of
the conformational propensities of peptides upon in-
teractions with lipid surfaces and provides insight
into the binding a⁄nity of peptides.
Another approach that yields information on the
various steps involved in the interaction of antimi-
crobial peptides and membranes is the use of ori-
ented lipid layers in CD spectroscopy [92]. Using
this technique, a transition from the surface-bound
peptide to a transmembrane state was reported for
alamethicin [93] and magainin 1 [94]. Alamethicin, a
hydrophobic antibiotic peptide of 19 amino acid res-
idues, contains a large amount of the unusual Aib
(i.e. eight Aib residues) and adopts an K-helical
structure in organic solvents [95]. Alamethicin and
other synthetic peptides rich in Aib residues were
reported to adopt a partial 310-helical structure
upon incorporation into bilayers [96,97]. Studies us-
ing oriented lipids in conjunction with CD spectros-
copy also showed that a number of K-helical peptides
initially lie parallel to the membrane plane at lower
lipid-to-peptide molar ratios and insert perpendicular
to the membrane plane above a certain threshold
concentration (e.g. around a lipid-to-peptide molar
ratio of 30 for magainin [94]). These ratios were
shown to depend strongly on the lipid composition
and hydration state. A similar behavior was also
suggested for the L-sheet peptide, protegrin 1,
although some di¡erences appear to exist when com-
pared to the K-helical peptides [98].
3.2. Fluorescence spectroscopy
Fluorescence spectroscopy is a highly sensitive
technique extensively used to study peptide^lipid
binding and peptide penetration into membranes.
The wide variety of £uorescence probes makes the
method suitable for studying a great range of inter-
actions. For example, the release of £uorescence dyes
from lipid vesicles provides useful information on
peptide binding ability and membrane perturbation
properties [7,99]. The leakage of dyes mediated by
the peptides was found, however, to be greatly af-
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fected by the mode of mixing the lipid and peptide
solutions, and therefore such experiments can lead to
erroneous conclusions on the membrane-lytic e¡ect
of peptides [99]. Due to the high sensitivity of £uo-
rospectrophotometers and ease of use, £uorescent
labeling has greatly replaced the earlier radioactive
labeling approach for peptide^lipid interaction and
penetration studies. Thus, peptide uptake into lipo-
somes can be determined by quantitating the £uores-
cence intensity of the £uorescent label (e.g. dansyl
group) of the remaining peptide in solution after sep-
aration by chromatographic techniques [100,101].
Measurements of quenching of tryptophan £uores-
cence by aqueous and hydrophobic quenchers are
also commonly used to study peptide penetration
into arti¢cial membranes [7], as well as peptide ag-
gregation state within a bilayer [102,103]. Recently,
measurements of the £uorescence decay of trypto-
phan emission provided information on the distribu-
tion of tryptophan rotamers for peptides bound to
phospholipid bilayers [104]. Thus, the distribution
and environment of tryptophan rotamers in pep-
tide^lipid complexes were found to depend on the
peptide sequences and induced conformations. As
for the other spectroscopic techniques described,
conclusions drawn from £uorescence experiments
on peptide orientation in the lipid bilayer, as well
as their aggregational state, remain controversial
and appear to be highly dependent on the systems
used for the particular studies.
Depth-dependent £uorescence technology, utilizing
lipids with bromine atoms or spin labels selectively
attached to certain positions along the acyl chains, is
an emerging technique to determine the structure of
membrane proteins, as well as to obtain information
on peptide penetration into membranes [49,103,105^
108]. The parallax method [109] and more recent
distribution analysis [110] are then used to extract
such information from the quenching data. The dif-
¢culties in using this technique derive from the un-
certainty of the local concentration of quenching lip-
ids and of the £uorescence of non-quenching lipids,
the existence of multiple conformations of mem-
brane-bound peptides, and incomplete binding.
Work presented by Rodionova et al. [111] and Lad-
hokin [105] using the outer membrane protein OmpA
and a membrane spanning peptide MSP, respec-
tively, have strengthened the suitability of this tech-
nique when combined with the distribution analysis
method for the evaluation of membrane penetration
of peptides and proteins. For example, a deeper in-
sertion of OmpA, combined with subsequent struc-
tural rearrangement which resulted in a di¡erent ex-
posure of tryptophan residues to the lipid quenchers,
could be detected using the distribution analysis
method, which was not detected using the parallax
method alone [111].
3.3. Attenuated total re£ection Fourier transform
infrared spectroscopy
ATR-FTIR represents a powerful tool to simulta-
neously study lipids and peptides without introduc-
ing a probe, since vibrational modes of both mole-
cules are present in the IR spectrum (the method
with its precautions and limitations are reviewed in
[112,113]). In contrast to most other spectroscopic
techniques, light scattering does not a¡ect such meas-
urements. FTIR spectroscopy can be performed ei-
ther as a transmission or an internal re£ection experi-
ment, the latter becoming widely used. A major
advantage of ATR-FTIR is that the absorption of
water molecules in the bu¡er solution is strongly
reduced as compared to transmission experiments.
Therefore, only small amounts of material (Wg range)
are necessary for recording IR spectra of membranes
and peptides. When using synthetic peptides, one has
to be aware that solvents commonly used in peptide
synthesis and puri¢cation, in particular tri£uoroacet-
ic acid, absorb in the range of the amide I band, and
therefore have to be thoroughly removed to allow a
detailed analysis. Polarized ATR-FTIR spectroscopy
also provides information on the orientation of dif-
ferent molecular parts of both the peptides and phos-
pholipids [114]. To evaluate the molecular orienta-
tions from dichroism data, the orientation of the
transition dipole moments as well as the refractive
index have to be known. In this respect, it was
pointed out that the determination of molecular or-
der in supported lipid membranes, in particular, in
the case of ¢lms which are much thinner than the IR
wavelength, critically depends on the assumptions
made about the evanescent electric ¢eld amplitudes
in the membrane [115]. The di⁄culties in overcoming
uncertainties on the orientation of the transition di-
pole moment and on the refractive index are dis-
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cussed by Goormaghtigh et al. [113], while the com-
plexity and in£uence of samples preparation on the
interpretation of spectroscopic data are discussed by
Tamm and Tatulian [112]. The potential of ATR-
FTIR to yield information on the orientation of pep-
tides in a membrane, an important aspect of under-
standing the molecular mechanism of membrane-ac-
tive peptides, was demonstrated with the synthetic
peptide LAH4 [113], which exhibits a pH-dependent
orientation as shown by solid state NMR spectros-
copy [116]. The presence of the amide I (1657 cm31)
and amide II (1546 cm31) bands indicate an K-helical
structure for this amphipathic peptide. Based on the
fact that the amide I dipole and amide II dipole are
nearly parallel and perpendicular to the helix long
axis, respectively, the orientation of LAH4 was de-
duced from the dichroic di¡erence spectra of the
parallel and perpendicular polarized spectra [113].
At pH 4, LAH4 was suggested to be oriented parallel
to the membrane plane of PC model membranes,
while at pH 9, it was perpendicular to the plane. In
addition, information on the hydrophobic, polar and
electrostatic contributions during membrane interac-
tion could be obtained due to the presence of histi-
dine residues, which have a pKa value around 5.5.
The interaction of melittin with model membranes
has been widely studied to gain information on the
location of this hemolytic peptide. Experiments using
supported PC bilayers showed that the orientation of
melittin strongly depended on the state of lipid hy-
dration, adopting a transmembrane orientation at
low hydration but aligning preferentially parallel to
the membrane surface in fully hydrated bilayers
[117]. Furthermore, this orientation is also a¡ected
by the lipid composition. Thus, CD and FTIR spec-
troscopy studies performed at low hydration revealed
that melittin is oriented perpendicular to the mem-
brane plane in the presence of saturated dimyristoyl-
phosphatidylcholine (DMPC) and dimyristoylphos-
phatidylglycerol (DMPG). In contrast, melittin lies
parallel to the membrane plane in the presence of
mono-unsaturated dioleoylphosphatidylcholine, dio-
leoylphosphatidylserine, and dioleoylphosphatidyl-
glycerol [118]. On the other hand, a transmembrane
orientation of melittin was found in oriented 1-pal-
mitoyl-2-oleoylphosphatidylcholine bilayers at ambi-
ent humidity [102,119]. Although no clear general
conclusions could be made regarding the orientation
of melittin when bound to membranes, the observed
signi¢cant e¡ects of the acyl chains indicated the in-
sertion of melittin into the membrane hydrophobic
core. Similar e¡ects were reported for the bacterio-
toxin N-lysin from S. aureus [119] and for transmem-
brane segments of the channel-forming peptide phos-
pholamban [120]. Thus, FTIR analysis of oriented
dipalmitoylphosphatidylcholine bilayers showed that
N-lysin lies randomly within the membrane [121]. On
the other hand, data from £uorescence experiments
indicated that the toxin lies parallel to the surface,
only weakly penetrating the hydrophobic core with
its apolar face [122]. Furthermore, 2H- and 31P-
NMR experiments showed that the location of the
peptide in the membrane depends on the experimen-
tal temperature relative to the gel-£uid phase transi-
tion temperature of dipalmitoylphosphatidylcholine
[123]. In contrast to these hemolytic peptides, polar-
ized ATR-FTIR studies showed that cecropin P1,
isolated from mammals, is oriented nearly parallel
to the membrane surface in model membranes con-
sisting of PE and PG (liposomes mimicking the phos-
pholipid composition of the inner membrane of Es-
cherichia coli [124]). This is consistent with
observations that the predominantly K-helical cecro-
pin P1 did not change signi¢cantly the order param-
eters of the acyl chains of the same PE/PG liposomes
[124].
In addition to the membrane location of peptides,
the conformational polymorphisms of small amphi-
pathic peptides can be deduced from FTIR studies,
which is of general interest in elucidating the mech-
anism(s) of action of these peptides. For example,
ATR-FTIR studies performed with peptide hor-
mones showed a conformational change from ran-
dom structure to L-sheet upon binding to lipid model
membranes [125,126]. A change in secondary struc-
ture was also found for human calcitonin upon bind-
ing to supported lipid bilayers. Initially, a small frac-
tion of K-helical structure was formed, while the
formation of a larger fraction of L-sheet structure
was kinetically delayed relative to the formation of
K-helix [127]. While signal peptides are expected to
form amphipathic helices [128], the secondary struc-
ture of the signal peptide of the E. coli V phage
receptor LamB was shown to depend on the packing
properties of lipid monolayers. At low surface pres-
sure, an K-helix was detected, whereas a L-sheet was
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formed at high surface pressure [129]. The in£uence
of the lipid-to-peptide molar ratio and lipid compo-
sition on the induced conformation of a synthetic
peptide corresponding to the N-terminal 23 amino
acid residues of the HIV envelope glycoprotein
gp41, which exhibits membrane fusion activity has
also been described [130,131]. In the presence of neg-
atively charged lipids, the peptide transformed from
an K-helical structure at low peptide concentrations
to a L-sheet at high peptide concentrations. The sur-
face-bound form was suggested to induce the aggre-
gation of lipid vesicles, while the inserted K-helical
form causes bilayer disruption [130]. Furthermore,
IR spectroscopy revealed that, in the absence of cat-
ions, the peptide which associated with the vesicles
was predominantly a pore-forming K-helix, whereas
in the presence of Ca2 the conformation switched to
a fusogenic, predominantly extended L-type struc-
ture. Liposomes composed of zwitterionic phospho-
lipids (i.e. PC and PE) and cholesterol also induced a
L-type structure that became fusogenic in a dose-de-
pendent fashion [132]. From these studies, it was
concluded that it is not an K-helical, but an extended
structure adopted by the HIV-1 fusion peptide that
destabilizes cholesterol-containing electrically neutral
membranes.
Detailed studies also exist on synthetic hydropho-
bic transmembrane helices. Systematic FTIR studies
revealed that the peptide K2GL24K2A-NH2 forms a
very stable transmembrane K-helix, although small
distortions of its K-helical conformation are induced
in response to any mismatch between peptide hydro-
phobic length and the hydrophobic thickness of the
PC bilayer [133]. Furthermore, the peptide alters the
conformational disposition of the acyl chains in con-
tact with it, minimizing the extent of hydrophobic
mismatch. This e¡ect was less pronounced using
PE model membranes [134]. In contrast to the poly-
leucine-based transmembrane helix, FTIR spectros-
copic data indicated that the conformation of Ac-
K2-(LA)12-K2-NH2 is sensitive to the composition
of the surrounding medium, with the occurrence of
conformational transitions from an K-helical to a
310-helical structure [135]. Furthermore, Ac-K2-
(LA)12-K2-NH2 retained a predominantly K-helical
conformation in both the gel and liquid^crystalline
phases of short to medium chain PC (hydrocarbon
chain length 6 18), but undergoes a reversible con-
formational change at the gel/liquid^crystalline phase
transition, when incorporated into bilayers composed
of long chain PC (hydrocarbon chain length v18)
[136].
Less is known about the conformational changes
of antimicrobial peptides that may be associated with
the individual steps of binding to the membrane sur-
face, penetration of the membrane interface, and in-
sertion into the bilayer hydrocarbon core. Polarized
ATR-FTIR spectroscopy of supported membrane
preparations (mono-, bi- and multilayers), combined
with the use of monomolecular lipid ¢lms formed at
the air^water interface of a Langmuir trough, pro-
vide useful models to investigate these di¡erent steps
of lipid^peptide interactions (Fig. 3) [112,137]. Early
FTIR studies on the interactions of melittin with
Fig. 3. Schematic representation of membrane model systems
that allow the study of: (a) binding of peptides to the mem-
brane surface (monolayer at high surface pressure) ; (b) penetra-
tion of peptides into the membrane interface (monolayer at low
surface pressure); and (c) membrane insertion of peptides (sup-
ported bilayer) by polarized ATR-FTIR spectroscopy. Sup-
ported monolayers can be also used instead of monolayers
formed at the air^water interface which are shown in the
scheme [137].
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phospholipid monolayers at di¡erent surface pres-
sures, and with small unilamellar vesicles above or
below their phase transition temperature, showed
that melittin, bound to the lipid surface, contains
less K-helical structure than when inserted into the
lipid bilayer [138]. Most interestingly, as the penetra-
tion depth of melittin increases, more ordered struc-
tures appear. This is in accordance with recent data
on cecropin A, which demonstrated that the peptide
inserts in both monolayer and bilayer model mem-
branes, but inserting deeper in bilayers, which results
in a more highly ordered peptide structure [137]. In
addition, the phospholipid bilayer was more signi¢-
cantly perturbed as compared to the lipid monolayer.
Minor changes in lipid absorption were attributed to
a reorientation of the lipid ester group out of the
membrane plane. Conformational changes were
also reported for nisin, a peptide widely used as an
antimicrobial food preservative. Although nisin is
stabilized by ¢ve thioether bonds providing some ri-
gidity to the peptide, its secondary structure is sensi-
tive to the solution environment [139]. The amide I
band indicated that the peptide adopts mainly unor-
dered and L-turn structures in water, while the addi-
tion of TFE or binding to membranes promoted the
formation of L-turns [140]. Nisin showed di¡erent
a⁄nity to negatively charged and zwitterionic lipids,
though the amide I band of the peptide bound to
these lipids was very similar. Furthermore, the phase
state of these lipids had no in£uence on the binding
a⁄nity of nisin, suggesting that the nature of the
membrane interface is less important for the action
of this peptide. Finally, amphipathic peptides con-
sisting of leucine and lysine residues of various
lengths (5^22 mer), designed to yield ideal K-helices
with a single lysine residue per putative turn [141],
were shown to exhibit length-dependent lytic activ-
ities, which was accompanied by a change of second-
ary structure [142]. Thus, in both the bulk solid state
and at the air^water interface, the shorter peptides
(nine residues and less) folded predominantly into
antiparallel L-sheets, whereas the longer peptides
adopted K-helical structures. Furthermore, in the
case of the shorter peptides, the random conforma-
tion present in the bulk state was not detected at the
air^water interface. This result suggested that the
interface induces a more strictly de¢ned peptide
structure. On the other hand, the structure and ori-
entation of the peptides did not depend on the nature
of the interface, i.e. air^water or DMPC monolayers
at various surface pressures. In summary, these ¢nd-
ings demonstrate that the £exibility of small amphi-
pathic peptides may play a role in their biological
activity.
3.4. Reversed phase-high performance liquid
chromatography
RP-HPLC has been shown to be a sensitive ana-
lytical tool for the study of peptide conformation at
aqueous^lipid interfaces [89,143^150]. The hydrocar-
bon groups of RP-HPLC columns have been shown
to induce alterations in secondary structure, which
results in variations in the retention behavior of se-
quence related peptides [143,146,147]. Thus, the dy-
namics of hydrophobic^hydrophobic interactions be-
tween peptides and the n-alkyl groups of the RP-
HPLC stationary phase lead to the induction of sec-
ondary structures speci¢c to each peptide. The devi-
ation between experimental retention times (RTs)
and the theoretical RTs calculated based on amino
acid retention coe⁄cients [151^153] is clearly due in
part to induced secondary structures. Therefore, the
sensitivity of the RP-HPLC systems lies in the fact
that peptides and proteins interact with these surfa-
ces in an orientation-speci¢c manner via a speci¢c
hydrophobic contact area. Changes in this hydro-
phobic contact area can occur as a result of confor-
mational or orientational changes, which, in turn,
alter the binding properties of the peptides. Thus,
RTs of peptides are a physical parameter which is
highly sensitive to the conformational status of the
peptides upon interaction with the hydrophobic sur-
face. For example, peptides that were able to be in-
duced into amphipathic K-helices were found to elute
signi¢cantly later than predicted, while those de-
signed to be inducible into L-sheet conformation
eluted earlier than predicted [143]. Furthermore, per-
turbation of the amphipathicity and/or helicity of
peptides by single or double sequence mutations
was found to correlate with variation in the peptides
retention behavior relative to the parent sequences
[11,89,147,148,154].
Comparative RP-HPLC and CD studies using C18-
coated plates [90] provided evidence for the occur-
rence of a continuum of induced conformations for
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L-sheet forming peptides at di¡erent equilibrium
stages during the RP-HPLC elution process (Fig.
4). In a ¢rst stage, the L-sheet conformations are
induced resulting from the interaction of the peptides
to the C18-groups of the stationary phase which com-
petes with intermolecular hydrophobic interactions.
This would explain the lower binding a⁄nity of
such peptides to lipid surfaces. In contrast, no com-
petition exists for hydrophobic interactions in the
case of K-helical peptides. The ¢nal stage of the
RP-HPLC elution process involves an equilibrium
between the peptide-bound L-sheet or K-helical con-
formation and free peptide K-helical conformation in
organic solvent (RP-HPLC mobile phase). The ex-
tent of the equilibrium shift depends on the speci¢c
binding a⁄nity of each peptide which then a¡ects the
peptide RT. Thus, the shift toward the free peptide
conformation occurs at a low percent of organic sol-
vent for L-sheet peptides having low binding a⁄n-
ities, which explains their observed early RTs. Based
on the distances between the hydrophobic and hy-
drophilic faces of amphipathic K-helical and L-sheet
peptides, the di¡erences in binding a⁄nity, and, in
turn, in RT between K-helical and L-sheet peptides,
can be rationalized by a moderate insertion of the
hydrophobic side into the lipid layer for L-sheet pep-
tides and a deeper penetration of the K-helical pep-
tides within the lipid layer (Fig. 4).
Temperature-dependent gradient elution RP-
HPLC has also been used to investigate the binding
properties of model amphipathic peptides with lipid-
like surfaces [154]. The interaction of the peptides
with the C18 ligands were characterized in terms of
the binding a⁄nity and hydrophobic binding domain
Fig. 4. Schematic of the conformational equilibria occurring during the RP-HPLC elution process of amphipathic L-sheet and K-heli-
cal peptides.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108 101
as a function of temperature. These studies revealed
that peptides adopting either an K-helix or L-sheet
upon adsorption to the surface undergo a signi¢cant
conformational transition. However, the rate of this
transition was much slower for K-helical peptides
relative to L-sheet-forming peptides, indicating the
stabilizing e¡ect of the hydrophobic surface on pep-
tide secondary structure. This phenomenon of di¡er-
ential stabilization of peptide secondary structure
upon binding to a hydrophobic surface cannot be
readily characterized by other techniques.
To understand the forces that control the speci¢c
binding and conformational changes of peptide^
membrane interactions, the analysis of the energetics
of binding and insertion of peptides into the mem-
brane, particularly as a function of peptide confor-
mation and lipid conformation and composition, is
an essential step towards the characterization of the
action of antimicrobial peptides. However, there
have been very few studies which have addressed
the binding characteristics of membrane-active pep-
tides in terms of their relative a⁄nity for di¡erent
phospholipids. This is due to the nature of the exist-
ing techniques which cannot be easily used to analyze
large numbers of peptides. Membrane-binding assays
with SUVs and LUVs generally require a physical
separation step to prepare distinct phases for analysis
by dialysis or centrifugation, which can be tedious
[155,156]. Alternatively, peptide partitioning can be
directly measured by changes in £uorescence quench-
ing or enhancement of tryptophan. However, this
approach relies on the presence of a £uorescent
probe, which if not an intrinsic £uorophore, must
be incorporated by covalent modi¢cation of the pep-
tide and/or lipid [157,158]. The RP-HPLC studies
described above clearly demonstrated the potential
of this technique for the quantitative determination
of the changes in the conformation and binding af-
¢nity of peptides as they interact with a lipid-like
surface. However, while the RP-HPLC sorbents pro-
vide a hydrophobic surface that may partially mimic
the physicochemical properties of lipid surfaces,
there are signi¢cant di¡erences between the confor-
mational and interactive properties of lipid mem-
branes and the n-alkylsilicas used in RP-HPLC.
The n-alkylsilicas do not contain a polar phosphate
head and do not exhibit the cooperative phase tran-
sition behavior characteristic of lipid bilayers. Thus,
in order to capitalize on the potential of RP-HPLC
techniques and incorporate the binding properties of
phospholipids, a model membrane which consists of
g-amino-phosphatidylcholine derivatives covalently
immobilized onto the activated surface of porous
silica-based particles has been synthesized and char-
acterized [159^161]. The interactive behavior of the
cytolytic peptide melittin with this model membrane
surface was examined as a function of methanol con-
centration and temperature using dynamic elution
analysis, analogous to procedures used in RP-
HPLC [154]. Melittin was found to exhibit complex
binding behavior upon adsorption to and elution
from the immobilized monolayer. In particular, a
transition was observed in the log kP values at 20%
methanol, while broad asymmetric and split peaks
were observed between 0 and 20% methanol. The
binding behavior observed for melittin with the
monolayer compared to the linear retention plots
Fig. 5. Schematic illustration of the interaction of melittin with
an immobilized phosphatidylcholine monolayer in aqueous con-
ditions at temperatures where (A) the lipid and/or melittin do
not undergo conformational interconversions, and (B) where in-
terconversions are present. The corresponding elution pro¢les
observed for melittin are also shown.
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and Gaussian peak shapes observed for the control
molecules suggests that melittin undergoes conforma-
tional changes upon binding to the immobilized PC
ligands as illustrated schematically in Fig. 5. This
methodology provides a novel approach to study
the di¡erent conformational and orientational e¡ects
which peptides undergo while interacting with mem-
branes surfaces and therefore o¡ers great potential in
the investigation of conformational transitions of
membrane-associating peptides. As outlined earlier,
the interaction of peptides with membrane surfaces
involves a number of steps which include initial bind-
ing to the phospholipids through a mixture of hydro-
phobic and electrostatic interactions, induction of
secondary structure upon binding, reorientation and
insertion of the peptide into the lipid membrane, and
further partitioning of the peptide in the membrane
[162]. The design and preparation of more complex
systems, which allow deeper penetration of the pep-
tide into the lipid layer, will expand the range of
biophysical tools available to investigate the molec-
ular basis of peptide^lipid interactions.
3.5. Surface plasmon resonance
SPR is an expanding technique based on biosensor
technology which allows the characterization of bio-
speci¢c interactions of label-free compounds [163].
One of the strengths of SPR is that it allows the
real time observation of the binding of ligands to a
target immobilized on the sensor surface [163]. Most
reports using SPR include the studies of protein^pro-
tein, protein^peptide, DNA^protein, DNA^DNA,
antibody^antigen, receptor^ligand, and lipid^protein
interactions [164^167]. Recently, lipid monolayers
were formed on an alkane-thiol self-assembled
monolayer mounted on a gold surface for SPR meas-
urements of the binding a⁄nity of amphipathic mol-
ecules for PC lipid monolayers [168,169]. The spon-
taneous fusion of the vesicles results in the formation
of a hybrid bilayer that resembles a membrane sur-
face as shown in Fig. 6. The rate of the formation of
these bilayers was found to be dependent on the lipid
concentration as well as on the di¡usion constant of
the lipid vesicles [168]. Thus, SUVs containing ana-
logs of bacterial mucopeptides were adsorbed onto
the surface of the hydrophobic self-assembled mono-
layer to mimic the surface of a bacterial membrane
[169]. A good correlation was then found between
the binding a⁄nity of di¡erent glycopeptide antibi-
otics to the inserted mucopeptide analogs and the in
vitro antimicrobial activity of these glycopeptides. In
contrast, no such correlation was obtained when
measuring the binding a⁄nities of the glycopeptides
to mucopeptide analogs free in solution. Using a
similar technique, the direct binding of peptides to
this hybrid bilayer surface can also be studied. The
resulting data then allow the thermodynamic analysis
of peptide^lipid interactions in terms of relative rate
constants and binding constants. Comparison of the
binding of melittin to a DMPC and a DMPG bilayer
revealed a much higher a⁄nity for DMPG (Fig. 7).
These results are in agreement with previous studies
Fig. 6. Schematic illustration of the preparation of the hybrid
bilayer system for SPR studies. The surface is composed of
self-assembled octadecyl alkyl chains covalently attached to a
gold surface. Upon application to the surface, SUVs absorb
spontaneously to form lipid multilayers which are then treated
to create a monolayer, thereby forming a hybrid bilayer.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108 103
[21] that have shown that melittin has a higher a⁄n-
ity for negatively charged phospholipids than for
zwitterionic lipids. Similarly, it was shown that the
binding capacity of the cationic antimicrobial pep-
tides cecropin B and its analog B1 increased as the
content of PA in the PC monolayer increased, but no
binding was found for the hydrophobic analog B3
[87]. Although cecropin B and B1 with a higher pos-
itive net charge bound more e¡ectively to liposomes
with an increasing content of negatively charged lip-
ids, their e⁄ciency in lysing these liposomes de-
creased while B3 became more potent in lysing
such liposomes. These results demonstrate that a
high binding a⁄nity of peptides to lipids does not
necessarily imply high ability to lyse membranes.
Using SPR, kinetic analyses of the interaction of
lysenin, a hemolytic protein isolated from the earth-
worm Eisenia foetida [170], with membrane surfaces
composed of SM were also recently reported [171].
These studies showed a high association of lysenin
with SM-containing membranes with a low dissocia-
tion constant. Furthermore, higher binding with no
change in the kinetic parameters of lysenin^mem-
brane interaction was obtained with membranes con-
taining both SM and cholesterol, indicating a high
speci¢city to SM relative to cholesterol. This is due
to changes in the distribution of SM in the mem-
branes caused by the insertion of cholesterol, which
increases the accessibility of SM to lysenin. Similarly,
the kinetics of the interaction of the peptide antibi-
otic polymyxin B and its analogs with lipopolysac-
charide (LPS) were determined by means of SPR
[172]. These studies showed that polymyxin B and
its analogs interact with LPS in a monoexponential
manner, and that the binding is dominated by hydro-
phobic and van der Waals forces. These results are in
agreement with earlier studies using isothermal titra-
tion calorimetry [173] and stop-£ow £uorescence
techniques [174]. Furthermore, the poor binding af-
¢nity to LPS observed for analogs lacking amphi-
pathic properties agreed with the premise that am-
phipathicity is necessary and su⁄cient for peptides to
bind to LPS [173,174]. Kinetics of the interaction
between LPS and lactoferrin-related antimicrobial
peptides were similarly carried out [175]. Thus, an
amphipathic K-helical region exposed on the outer
surface of lactoferrin was found by SPR to bind
speci¢cally to LPS of E. coli O111. These results
showed the importance of this region to the binding
and antimicrobial pathogenesis of lactoferrin.
Overall, SPR is a more rapid and convenient tech-
nique than the existing separation-based and £uores-
cence-based techniques and has the potential to pro-
vide a new complementary experimental approach to
the study of the action of antimicrobial peptides.
4. Correlation between lipid-induced conformation
and/or binding a⁄nity and lytic activity of peptides
Attempts to correlate the antimicrobial, antifun-
gal, and/or hemolytic activity of peptides with their
induced conformation in various lipid environments
are part of most of the studies directed toward
understanding the mechanism of action of these pep-
tides, as well as toward the design of novel thera-
peutically useful peptides. As anticipated, great var-
iations in activity are often obtained when
comparing antimicrobial or antifungal activities to
hemolytic activities, and a number of naturally oc-
curring and engineered peptides exhibit signi¢cantly
greater antimicrobial activities than hemolytic activ-
ities. In contrast, subtle variations in activities often
exist when comparing activity against di¡erent bac-
terial and/or fungal species. Due to the di⁄culties in
completely mimicking the changes in membrane
compositions between microorganisms and/or bacte-
rial strains, the relationship between the peptide anti-
microbial and antifungal speci¢cities and the pep-
Fig. 7. Sensorgrams obtained using SPR detection of the inter-
action of melittin (at 90 WM) with a hybrid bilayer (illustrated
in Fig. 6) composed of DMPC or DMPG. The response is pro-
portional to the amount of peptide absorbed to the hybrid bi-
layer and hence to the a⁄nity of melittin for the lipid surface.
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tide^lipid binding preferences is not totally under-
stood.
As shown for several antimicrobial peptides, bind-
ing preferences to certain lipid types can be somehow
related to the peptide speci¢city toward given micro-
organisms. In particular, cationic peptides disrupt
membranes composed of acidic phospholipids better
than those composed of zwitterionic phospholipids.
For example, magainin was found to e¡ectively per-
meabilize PG-rich membranes and to more e¡ectively
kill bacteria whose inner membranes contain higher
amounts of PG [6]. Similarly, the antimicrobial pep-
tide semiplasmin exhibits higher a⁄nity to negatively
charged dioleoylphosphatidylglycerol vesicles than to
zwitterionic lipids (the extracytosplasmic region of
erythrocyte cells is composed of zwitterionic lipids),
which could re£ect the lack of hemolytic activity at
the concentration where it exerts its antimicrobial
activity [7]. Sapecin also exhibits a speci¢c a⁄nity
for diphosphatidylglycerol [8]. On the other hand,
the hemolytic peptide cinnamycin appears to have
speci¢city for the zwitterionic lipid PE [9]. Preincu-
bation of cinnamycin with PE signi¢cantly reduces
the extent of hemolysis induced by this peptide. In
addition, the permeability of PE-containing lipo-
somes is increased by cinnamycin, but this does not
occur with liposomes composed of other phospholip-
ids.
Peptide^C18 interactions were also found to pro-
vide insight into biomolecular recognition events at
aqueous^phospholipid membrane interfaces. Using
di¡erent series of sequence-related amphipathic K-
helical peptides, excellent correlations were observed
between the antimicrobial activities and the RTs dur-
ing RP-HPLC [11,147]. Excellent correlations were
also reported between the RP-HPLC behavior of
the L-sheet peptide analogs of cyclic gramicidin S
and their binding a⁄nity to bacterial LPS, as well
as between the RP-HPLC retention times and hemo-
lytic activities of these peptides [54].
5. Conclusions
The interaction between cytolytic peptides and lip-
id bilayers plays a crucial role in their membrane
perturbation activity and/or disruption of cellular
function, and subsequent cell death. During these
interactions, peptides generally exhibit a conforma-
tional transition from extended random coil in aque-
ous environment to a stabilized unique secondary
structure upon interaction with the membrane, which
is either preceded by or followed by enhanced bind-
ing through electrostatic interactions. The dynamic
interactions between the peptides and membrane lip-
ids are therefore key elements in the biological activ-
ities of the peptides as well as in the speci¢city of
their activity. Furthermore, the determination of the
relative contribution of each of these interactions to
the overall binding and function clearly depend on
the speci¢c sequence and membrane system used.
Studies using the techniques described in this review
have clearly demonstrated the complexity of peptide^
membrane interactions in terms of the mutual
changes in peptide binding, conformation, orienta-
tion, and lipid organization, and have to a certain
extent allowed correlations to be drawn between pep-
tide conformation properties and lytic activity. While
great progress has been made in the last decade
thanks to such techniques, development of stable
membrane systems, that incorporate all of the ele-
ments making up the complexity of natural mem-
branes and of the dynamic of peptide^membrane in-
teractions, combined with sensitive analytical and
spectroscopic techniques, will provide greater insight
into the molecular basis of antimicrobial peptide ac-
tion.
Acknowledgements
We thank Neeta Padgaonkar and Henriette Moz-
solits who performed the unpublished CD and SPR
binding experiments, respectively, included here, and
the Australian Research Council for ¢nancial sup-
port.
References
[1] J. Nissen-Meyer, I.F. Nes, Arch. Microbiol. 167 (1997) 67^
77.
[2] K. Lohner, R.M. Epand, Adv. Biophys. Chem. 6 (1997) 53^
66.
[3] C.B. Park, H.S. Kim, S.C. Kim, Biochem. Biophys. Res.
Commun. 244 (1998) 253^257.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108 105
[4] S. Sharma, I. Verma, G.K. Khuller, Arch. Microbiol. 171
(1999) 338^342.
[5] R.I. Lehrer, A. Barton, K.A. Daher, S.S.L. Harwig, T.
Ganz, M.E. Selsted, J. Clin. Invest. 84 (1989) 553^561.
[6] K. Matsuzaki, K. Sugishita, M. Harada, N. Fujii, K. Miya-
jima, Biochim. Biophys. Acta 1327 (1997) 119^130.
[7] N. Sitaram, R. Nagaraj, Biochemistry 32 (1993) 3124^3130.
[8] K. Matsuyama, S. Natori, J. Biochem. 108 (1990) 128^132.
[9] S.Y. Choung, T. Kobayashi, K. Takemoto, H. Ishitsuka, K.
Inoue, Biochim. Biophys. Acta 940 (1988) 180^187.
[10] E.T. Kaiser, F.J. Ke¤zdy, Annu. Rev. Biophys. Biophys.
Chem. 16 (1987) 561^581.
[11] S.E. Blondelle, R.A. Houghten, Biochemistry 31 (1992)
12688^12694.
[12] G. Saberwal, R. Nagaraj, Biochim. Biophys. Acta 1197
(1994) 109^131.
[13] H.G. Boman, Annu. Rev. Immunol. 13 (1995) 61^92.
[14] W.L. Maloy, U.P. Kari, Biopolymers 37 (1995) 105^122.
[15] D.R. Storm, K.S. Rosenthal, P.E. Swanson, Annu. Rev.
Biochem. 46 (1977) 723^763.
[16] J. Viitala, J. Ja«rnefelt, Trends Biotechnol. 14 (1985) 392^395.
[17] D. Wade, A. Boman, B. Wafihlin, C.M. Drain, D. Andreu,
H.G. Boman, R.B. Merri¢eld, Proc. Natl. Acad. Sci. USA
87 (1990) 4761^4765.
[18] R. Bessalle, A. Kapitkovsky, A. Gorea, I. Shalit, M. Frid-
kin, FEBS Lett. 274 (1990) 151^155.
[19] P. Juvvadi, S. Vunnam, R.B. Merri¢eld, J. Am. Chem. Soc.
118 (1996) 8989^8997.
[20] S.E. Blondelle, E. Takahashi, K.T. Dinh, R.A. Houghten,
J. Appl. Bacteriol. 78 (1995) 39^46.
[21] C.E. Dempsey, Biochim. Biophys. Acta 1031 (1990) 143^161.
[22] J.H. Cuervo, B. Rodriguez, R.A. Houghten, Pept. Res. 1
(1988) 81^86.
[23] M. Monette, M. La£eur, Biophys. J. 68 (1995) 187^195.
[24] K. Matsuzaki, O. Murase, N. F ujii, K. Miyajima, Biochem-
istry 35 (1996) 11361^11368.
[25] K. Matsuzaki, M. Harada, S. Funakoshi, N. Fujii, K. Miya-
jima, Biochim. Biophys. Acta 1063 (1991) 162^170.
[26] T. Wieprecht, M. Dathe, M. Schu«mann, E. Krause, M. Bey-
ermann, M. Bienert, Biochemistry 35 (1996) 10844^10853.
[27] A. Vaz Gomes, A. de Waal, J.A. Berden, H.V. Westerho¡,
Biochemistry 32 (1993) 5365^5372.
[28] T. Wieprecht, M. Dathe, E. Krause, M. Beyermann, W.L.
Maloy, D.L. MacDonald, M. Bienert, FEBS Lett. 417 (1997)
135^140.
[29] A. Latal, G. Degovics, R.F. Epand, R.M. Epand, K. Loh-
ner, Eur. J. Biochem. 248 (1997) 938^946.
[30] K. Lohner, A. Latal, R.I. Lehrer, T. Ganz, Biochemistry 36
(1997) 1525^1531.
[31] C.P. Hill, J. Yee, M.E. Selsted, D. Eisenberg, Science 251
(1991) 1441^1485.
[32] X.L. Zhang, M.E. Selsted, A. Pardi, Biochemistry 31 (1992)
11348^11356.
[33] S.S. Harwig, K.M. Swiderek, T.D. Lee, R.I. Lehrer, J. Pept.
Sci. 1 (1995) 207^215.
[34] H. Tamamura, R. Ikoma, M. Niwa, S. Funakoshi, T. Mu-
rakami, N. Fujii, Chem. Pharm. Bull. 41 (1993) 978^980.
[35] I.L. Karle, P. Balaram, Biochemistry 29 (1990) 6747^6756.
[36] D.A. Langs, Science 241 (1988) 188^191.
[37] D.A. Langs, G.D. Smith, C. Courseille, G. Precigoux, M.
Hospital, Proc. Natl. Acad. Sci. USA 88 (1991) 5345^5349.
[38] B.A. Wallace, K. Ravikumar, Science 241 (1988) 182^187.
[39] G. Jung, Angew. Chem. Int. Ed. Engl. 30 (1991) 1051^1192.
[40] E.J. Prenner, R.N.A.H. Lewis, K.C. Neuman, S.N. Gruner,
L.H. Kondejewski, R.S. Hodges, R.N. McElhaney, Bio-
chemistry 36 (1997) 7906^7916.
[41] R. Miller, N.M. Galitsky, W.L. Duax, D.A. Langs, V.Z.
Pletnev, V.T. Ivanov, Int. J. Pept. Protein Res. 42 (1993)
539^549.
[42] V. Cabiaux, B. Agerberth, J. Johansson, F. Homble¤, E.
Goormaghtigh, J.-M. Ruysschaert, Eur. J. Biochem. 224
(1994) 1019^1027.
[43] H.G. Boman, B. Agerberth, A. Boman, Infect. Immun. 61
(1993) 2978^2984.
[44] T.J. Falla, D.N. Karunaratne, R.E. Hancock, J. Biol. Chem.
271 (1996) 19298^19303.
[45] M. Dathe, T. Wieprecht, H. Nikolenko, L. Handel, W.L.
Maloy, D.L. MacDonald, M. Beyermann, M. Bienert,
FEBS Lett. 403 (1997) 208^212.
[46] S.E. Blondelle, R.A. Houghten, Biochemistry 30 (1991)
4671^4678.
[47] S.E. Blondelle, R.A. Houghten, Pept. Res. 4 (1991) 12^18.
[48] T. Kiyota, S. Lee, G. Sugihara, Biochemistry 35 (1996)
13196^13204.
[49] Z. Oren, Y. Shai, Biochemistry 36 (1997) 1826^1835.
[50] Y. Shai, Z. Oren, J. Biol. Chem. 271 (1996) 7305^7308.
[51] S.E. Blondelle, E. Takahashi, R.A. Houghten, E. Pe¤rez-
Paya¤, Biochem. J. 313 (1996) 141^147.
[52] M. Dathe, M. Schumann, T. Wieprecht, A. Winkler, M.
Beyermann, E. Krause, K. Matsuzaki, O. Murase, M. Bien-
ert, Biochemistry 35 (1996) 12612^12622.
[53] L.H. Kondejewski, S.W. Farmer, D.S. Wishart, R.E.W.
Hancock, R.S. Hodges, Int. J. Pept. Protein Res. 47 (1996)
460^466.
[54] L.H. Kondejewski, M. Jelokhani-Niaraki, S.W. Farmer, B.
Lix, C.M. Kay, B.D. Sykes, R.E.W. Hancock, R.S. Hodges,
J. Biol. Chem. 274 (1999) 13181^13192.
[55] H.G. Boman, D. Wade, I.A. Boman, B. Wafihlin, R.B. Merri-
¢eld, FEBS Lett. 259 (1) (1989) 103^106.
[56] D. Andreu, J. Ubach, A. Boman, B. Wafihlin, D. Wade, R.B.
Merri¢eld, H.G. Boman, FEBS Lett. 296 (2) (1992) 190^194.
[57] D. Wade, D. Andreu, S.A. Mitchell, A.M.V. Silveira, A.
Boman, H.G. Boman, R.B. Merri¢eld, Int. J. Pept. Protein
Res. 40 (1992) 429^436.
[58] S.Y. Shin, M.K. Lee, K.L. Kim, K.S. Hahm, J. Pept. Res. 50
(1997) 279^285.
[59] S.Y. Shin, J.H. Kang, K.S. Hahm, J. Pept. Res. 53 (1999)
82^90.
[60] E.J. Helmerhorst, I.M. Reijnders, W. Van ’t Hof, E.C.I.
Veerman, A.V.N. Amerongen, FEBS Lett. 449 (1999) 105^
110.
[61] L. Zhong, W.C. Johnson Jr., Proc. Natl. Acad. Sci. USA 89
(1992) 4462^4465.
[62] A. Jasano¡, A.R. Fersht, Biochemistry 33 (1994) 2129^2135.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108106
[63] S. Takahashi, Biochemistry 29 (1990) 6257^6264.
[64] M. Zaslo¡, Proc. Natl. Acad. Sci. USA 84 (1987) 5449^5453.
[65] R.W. Williams, R. Starman, K.M.P. Taylor, K. Gable, T.
Beeler, M. Zaslo¡, D. Covell, Biochemistry 29 (1990) 4490^
4496.
[66] K. Matsuzaki, A. Nakamura, O. Murase, K. Sugishita, N.
Fujii, K. Miyajima, Biochemistry 36 (1997) 2104^2111.
[67] E. Habermann, Science 177 (1972) 314^322.
[68] A. Okada, K. Wakamatsu, T. Miyazawa, T. Higashijima,
Biochemistry 33 (1994) 9438^9446.
[69] D.V. Waterhous, W.C. Johnson Jr., Biochemistry 33 (1994)
2121^2128.
[70] C.S.C. Wu, J.T. Yang, Mol. Cell. Biochem. 40 (1981) 109^
122.
[71] J. Rizo, F.J. Blanco, B. Kobe, M.D. Bruch, L.M. Gierasch,
Biochemistry 32 (1993) 4881^4894.
[72] S.E. Blondelle, B. Forood, R.A. Houghten, E. Pe¤rez-Paya¤,
Biopolymers 42 (1997) 489^498.
[73] J.H. Fendler, Science 223 (1984) 888^894.
[74] M. Winterhalter, D.D. Lasic, Chem. Phys. Lipids 64 (1993)
35^43.
[75] M.A. Yorek, in: G. Cevc (Ed.), Phospholipids Handbook,
Marcel Dekker, New York, NY, 1993, pp. 745^775.
[76] W.M. O’Leary, S.G. Wilkinson, in: C. Ratledge, S.G. Wil-
kinson (Eds.), Microbial Lipids, Vol. 1, Academic Press,
London, 1988, pp. 117^201.
[77] S.G. Wilkinson, in: C. Ratledge, S.G. Wilkinson (Eds.), Mi-
crobial Lipids, Academic Press, London, 1988, pp. 299^
488.
[78] D. Andreu, H. Aschauer, G. Kreil, R.B. Merri¢eld, Eur. J.
Biochem. 149 (1985) 531^535.
[79] A.E. Shinnar, L.R. Olsen, G.H. Reed, J.S. Leigh, M.A. Zas-
lo¡, in: R.S. Hodges, J.A. Smith (Eds.), Peptides. Chemistry,
Structure and Biology. Proceedings of the Thirteenth Amer-
ican Peptide Symposium, ESCOM, Leiden, 1994, pp. 820^
822.
[80] M. Jackson, H.H. Mantsch, J.H. Spencer, Biochemistry 31
(1992) 7289^7293.
[81] K. Matsuzaki, M. Harada, T. Handa, S. Funakoshi, N. Fu-
jii, H. Yajima, K. Miyajima, Biochim. Biophys. Acta 981
(1989) 130^134.
[82] T. Wieprecht, M. Dathe, M. Beyermann, E. Krause, W.L.
Maloy, D. MacDonald, M. Bienert, Biochemistry 36 (1997)
6124^6132.
[83] H. Steiner, D. Hultmark, Aî . Engstro«m, H. Bennich, H.G.
Boman, Nature 292 (1981) 246^248.
[84] T.A. Holak, A. Engstrom, P.J. Kraulis, G. Lindeberg, H.
Bennich, T.A. Jones, A.M. Gronenborn, G.M. Clore, Bio-
chemistry 27 (1988) 7620^7629.
[85] D. Sipos, M. Andersson, A. Ehrenberg, Eur. J. Biochem. 209
(1992) 163^169.
[86] H.M. Chen, W. Wang, D. Smith, S.C. Chan, Biochim. Bio-
phys. Acta 1336 (1997) 171^179.
[87] W. Wang, D.K. Smith, K. Moulding, H.M. Chen, J. Biol.
Chem. 273 (1998) 27438^27448.
[88] E. Gazit, A. Boman, H.G. Boman, Y. Shai, Biochemistry 34
(1995) 11479^11488.
[89] S.E. Blondelle, J.M. Ostresh, R.A. Houghten, E. Pe¤rez-
Paya¤, Biophys. J. 68 (1995) 351^359.
[90] S.E. Blondelle, B. Forood, E. Pe¤rez-Paya¤, R.A. Houghten,
Int. J. Bio-Chromatogr. 2 (1996) 133^144.
[91] R. Montserret, E. Aubert-Foucher, M.J. McLeish, J.M.
Hill, D. Ficheux, M. Jaquinod, M. van der Rest, G. Dele¤-
age, F. Penin, Biochemistry 38 (1999) 6479^6488.
[92] Y. Wu, H.W. Huang, G.A. Olah, Biophys. J. 57 (1990)
797^806.
[93] H.W. Huang, Y. Wu, Biophys. J. 60 (1991) 1079^1087.
[94] S.J. Ludtke, K. He, Y. Wu, H.W. Huang, Biochim. Bio-
phys. Acta 1190 (1994) 181^184.
[95] R.O. Fox Jr., F.M. Richards, Nature 300 (1982) 325^330.
[96] P.I. Haris, D. Chapman, Biochim. Biophys. Acta 943
(1988) 375^380.
[97] D.F. Kennedy, M. Crisma, C. Toniolo, D. Chapman, Bio-
chemistry 30 (1991) 6541^6548.
[98] W.T. Heller, A.J. Waring, R.I. Lehrer, H.W. Huang, Bio-
chemistry 37 (1998) 17331^17338.
[99] I.V. Polozov, A.I. Polozova, G.M. Anantharamaiah, J.P.
Segrest, R.M. Epand, Biochem. Mol. Biol. Int. 33 (1994)
1073^1079.
[100] J.W. Payne, G. Bell, J. Bacteriol. 137 (1979) 447^455.
[101] J.W. Payne, T.M. Nisbet, FEBS Lett. 119 (1980) 73^76.
[102] A.J. Weaver, M.D. Kemple, J.W. Brauner, R. Mendelsohn,
F.G. Prendergast, Biochemistry 31 (1992) 1301^1313.
[103] K. Matsuzaki, O. Murase, H. Tokuda, S. Funakoshi, N.
Fujii, K. Miyajima, Biochemistry 33 (1994) 3342^3349.
[104] A.H.A. Clayton, W.H. Sawyer, Biophys. J. 76 (1999) 3235^
3242.
[105] A.S. Ladokhin, Biophys. J. 76 (1999) 946^955.
[106] L.A. Chung, J.D. Lear, W.F. DeGrado, Biochemistry 31
(1992) 6608^6616.
[107] J.D. Jones, L.M. Gierasch, Biophys. J. 67 (1994) 1534^
1545.
[108] V.K. Mishra, M.N. Palgunachari, Biochemistry 35 (1996)
11210^11220.
[109] F.S. Abrams, E. London, Biochemistry 32 (1993) 10826^
10831.
[110] A.S. Ladokhin, Methods Enzymol. 278 (1997) 462^473.
[111] N.A. Rodionova, S.A. Tatulian, T. Surrey, F. Ja«hnig, L.K.
Tamm, Biochemistry 34 (1995) 1921^1929.
[112] L.K. Tamm, S.A. Tatulian, Q. Rev. Biophys. 30 (1997)
365^429.
[113] E. Goormaghtigh, V. Raussens, J.M. Ruysschaert, Bio-
chim. Biophys. Acta 1422 (1999) 105^185.
[114] E. Goormaghtigh, J.M. Ruysschaert, in: R. Brasseur (Ed.),
Molecular Description of Biological Membranes by Com-
puter Aided Conformational Analysis, CRC Press, Boca
Raton, FL, 1990, pp. 285^329.
[115] M.J. Citra, P.H. Axelsen, Biophys. J. 71 (1996) 1796^1805.
[116] B. Bechinger, J. Mol. Biol. 263 (1996) 768^775.
[117] S. Frey, L.K. Tamm, Biophys. J. 60 (1991) 922^930.
[118] H.H. de Jongh, E. Goormaghtigh, J.A. Killian, Biochemis-
try 33 (1994) 14521^14528.
[119] J.W. Brauner, R. Mendelsohn, F.G. Prendergast, Biochem-
istry 26 (1987) 8151^8158.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108 107
[120] S.A. Tatulian, L.R. Jones, L.G. Reddy, D.L. Stokes, L.K.
Tamm, Biochemistry 34 (1995) 4448^4456.
[121] J.W. Brauner, R. Mendelsohn, F.G. Prendergast, Biochem-
istry 26 (1999) 8151^8158.
[122] E. Thiaudiere, O. Si¡ert, J. Talbot, J. Bolard, J.E. Alouf, J.
Dufourcq, Eur. J. Biochem. 195 (1991) 203^213.
[123] E.J. Dufourc, J. Dufourcq, T.H. Birkbeck, J.H. Freer, Eur.
J. Biochem. 187 (1990) 581^587.
[124] E. Gazit, I.R. Miller, P.C. Biggin, M.S. Sansom, Y. Shai,
J. Mol. Biol. 258 (1996) 860^870.
[125] W.K. Surewicz, H.H. Mantsch, G.L. Stahl, R.M. Epand,
Proc. Natl. Acad. Sci. USA 84 (1987) 7028^7030.
[126] W.K. Surewicz, H.H. Mantsch, J. Am. Chem. Soc. 110
(1988) 4412^4414.
[127] H.H. Bauer, M. Mu«ller, J. Goette, H.P. Merkle, U.P. Frin-
geli, Biochemistry 33 (1994) 12276^12282.
[128] L.K. Tamm, Biochim. Biophys. Acta 1071 (1991) 123^
148.
[129] D.G. Cornell, R.A. Dluhy, M.S. Briggs, C.J. McKnight,
L.M. Gierasch, Biochemistry 28 (1989) 2789^2797.
[130] M. Rafalski, J.D. Lear, W.F. DeGrado, Biochemistry 29
(1990) 7917^7922.
[131] J.L. Nieva, S. Nir, A. Muga, F.M. Goni, J. Wilscut, Bio-
chemistry 33 (1994) 3201^3209.
[132] F.B. Pereira, F.M. Goni, A. Muga, J.L. Nieva, Biophys. J.
73 (1997) 1977^1986.
[133] Y.-P. Zhang, R.N. Lewis, R.S. Hodges, R.N. McElhaney,
Biochemistry 31 (1992) 11572^11578.
[134] Y.-P. Zhang, R.N.A.H. Lewis, R.S. Hodges, R.N. McElha-
ney, Biophys. J. 68 (1995) 847^857.
[135] Y.-P. Zhang, R.N.A.H. Lewis, G.D. Henry, B.D. Sykes,
R.S. Hodges, R.N. McElhaney, Biochemistry 34 (1995)
2348^2361.
[136] Y.-P. Zhang, R.N.A.H. Lewis, R.S. Hodges, R.N. McElha-
ney, Biochemistry 34 (1995) 2362^2371.
[137] L. Silvestro, P.H. Axelsen, Chem. Phys. Lipids 96 (1998)
69^80.
[138] S.-F. Sui, H. Wu, Y. Guo, K.-S. Chen, J. Biochem. 116
(1994) 482^487.
[139] W. Liu, J.N. Hansen, Appl. Environ. Microbiol. 56 (1990)
2551^2558.
[140] R. El-Jastimi, M. La£eur, Biochim. Biophys. Acta 1324
(1997) 151^158.
[141] S. Castano, I. Cornut, K. Bu«ttner, J.L. Dasseux, J.
Dufourcq, Biochim. Biophys. Acta 1416 (1999) 161^
175.
[142] S. Castano, B. Desbat, M. Laguerre, J. Dufourcq, Biochim.
Biophys. Acta 1416 (1999) 176^194.
[143] J.M. Ostresh, K. Bu«ttner, R.A. Houghten, in: C. Mant,
R.S. Hodges (Eds.), HPLC of Peptides and Proteins: Sep-
aration, Analysis, and Conformation, CRC Press, Boca
Raton, FL, 1991, pp. 633^642.
[144] R.A. Houghten, J.M. Ostresh, Biochromatography 2 (1987)
80^84.
[145] F.E. Regnier, Science 238 (1987) 319.
[146] S.E. Blondelle, K. Bu«ttner, R.A. Houghten, J. Chromatogr.
625 (1992) 199^206.
[147] K. Bu«ttner, S.E. Blondelle, J.M. Ostresh, R.A. Houghten,
Biopolymers 32 (1992) 575^583.
[148] E. Krause, M. Beyermann, M. Dathe, S. Rothemund, M.
Bienert, Anal. Chem. 67 (1995) 252^258.
[149] E. Lazoura, I. Maidonis, E. Bayer, M.T.W. Hearn, M.-I.
Aguilar, Biophys. J. 72 (1997) 238^246.
[150] R.S. Hodges, B.Y. Zhu, N.E. Zhou, C.T. Mant, J. Chro-
matogr. 676 (1994) 3^15.
[151] J.L. Meek, Z.L. Rossetti, J. Chromatogr. 211 (1981) 15^28.
[152] T. Sasagawa, T. Okuyama, D.C. Teller, J. Chromatogr. 240
(1982) 329^340.
[153] D. Guo, C.T. Mant, A.K. Taneja, J.M.R. Parker, R.S.
Hodges, J. Chromatogr. 359 (1986) 499^517.
[154] D.L. Steer, P.E. Thompson, S.E. Blondelle, R.A. Hought-
en, M.I. Aguilar, J. Pept. Res. 51 (1998) 401^412.
[155] W.C. Wimley, S.H. White, Anal. Biochem. 213 (1993) 213^
217.
[156] R.E. Jacobs, S.H. White, Biochemistry 28 (1989) 3421^
3437.
[157] J.B. Heymann, S.D. Zakharov, Y.L. Yang, W.A. Cramer,
Biochemistry 35 (1996) 2717^2725.
[158] J.M. Del¢no, S.L. Schreiber, F.M. Richards, J. Am. Chem.
Soc. 115 (1993) 3458^3474.
[159] T.-H. Lee, D. Rivett, J. Werkmeister, D. Hewish, M.I.
Aguilar, Lett. Pept. Sci. 5 (1999) 1^10.
[160] H. Mozsolits, T.-H. Lee, H.-J. Wirth, P. Perlmutter, M.I.
Aguilar, Biophys. J., in press.
[161] T.-H. Lee, A.H.A. Clayton, W.H. Sawyer, H.-J. Wirth, P.
Perlmutter, M.I. Aguilar, Biochemistry, submitted for pub-
lication.
[162] S.H. White, W.C. Wimley, Biochim. Biophys. Acta 1376
(1998) 339^352.
[163] P. Schuck, Annu. Rev. Biophys. Biomol. Struct. 26 (1997)
541^566.
[164] L.J.N. Cooper, D. Roberson, R. Granzow, N.S. Green-
span, Mol. Immunol. 31 (1994) 577^584.
[165] F.L. Rock, D. Peterson, B.C. Weig, R.A. Kastelein, J.F.
Bazan, Horm. Metab. Res. 28 (1996) 748^750.
[166] V.V. Shuvaev, G. Siest, FEBS Lett. 383 (1996) 9^12.
[167] W.-P. Yang, H. Wu, C.F. Barbas III, J. Immunol. Methods
183 (1995) 175^182.
[168] J.B. Hubbard, V. Silin, A.L. Plant, Biophys. Chem. 75
(1998) 163^176.
[169] M.A. Cooper, A.C. Try, J. Carroll, D.J. Ellar, D.H. Wil-
liams, Biochim. Biophys. Acta 1373 (1998) 101^111.
[170] Y. Sekizawa, T. Kubo, H. Kobayashi, T. Nakajima, S.
Natori, Gene 191 (1997) 97^102.
[171] A. Yamaji, Y. Sekizawa, K. Emoto, H. Sakuraba, K. In-
oue, H. Kobayashi, M. Umeda, J. Biol. Chem. 273 (1998)
5300^5306.
[172] C.J. Thomas, A. Surolia, FEBS Lett. 445 (1999) 420^424.
[173] S. Srimal, N. Surolia, S. Balasubramanian, A. Surolia, Bio-
chem. J. 315 (1996) 679^686.
[174] C.J. Thomas, B.P. Gangadhar, N. Surolia, A. Surolia,
J. Am. Chem. Soc. 120 (1998) 12428^12434.
[175] D.S. Chapple, D.J. Mason, C.L. Joannou, E.W. Odell, V.
Gant, R.W. Evans, Infect. Immun. 66 (1998) 2434^2440.
BBAMEM 77746 26-11-99
S.E. Blondelle et al. / Biochimica et Biophysica Acta 1462 (1999) 89^108108
